The "lazy" NK cells of Chediak-Higashi syndrome
- PMID: 6602174
The "lazy" NK cells of Chediak-Higashi syndrome
Abstract
Natural killer (NK) function, measured in a short-term (4-hr) 51Cr-release assay, is profoundly depressed in circulating PBL of donors with Chediak-Higashi syndrome (CHS). In this study, we demonstrate that CHS NK cells can express relatively normal lytic function after prolonged exposure in vitro to high levels of activating as well as cytotoxic stimuli. After activation with the human cloned interferon (B1) for 24 hr, CHS NK cells have lytic activity comparable to unactivated normals in a 4-hr 51Cr-release assay. In addition, after 5 days of activation with mitomycin C-treated B cell lines, CHS NK cells have levels of activity similar to those of activated normals but are defective in generating cytotoxic cells capable of lysing the stimulator B cell. Even though CHS NK cells are defective in a 4-hr 51Cr-release assay, after 16 hr they enhance their killing capability 200 to 400-fold. In fact, after 16 hr of interaction with K562 target cells, CHS NK cells are capable of releasing NK soluble cytotoxic factors. These results are consistent with the hypothesis that CHS NK cells have all the necessary cellular structures and molecules required for them to function as lytic effector cells, but their lack of cytotoxic function is due to a relative refractoriness in initiating the post-binding lytic mechanism.
Similar articles
-
Herpesvirus saimiri-transformed CD8+ T cells as a tool to study Chediak-Higashi syndrome cytolytic lymphocytes.J Leukoc Biol. 2005 May;77(5):661-8. doi: 10.1189/jlb.0904500. Epub 2005 Feb 22. J Leukoc Biol. 2005. PMID: 15728247
-
Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).J Immunol. 1983 Jun;130(6):2965-8. J Immunol. 1983. PMID: 6189909
-
Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).J Immunol. 1983 Jun;130(6):2960-4. J Immunol. 1983. PMID: 6189908
-
Delivering the kiss of death.Nat Immunol. 2003 May;4(5):399-403. doi: 10.1038/ni0503-399. Nat Immunol. 2003. PMID: 12719728 Review.
-
Natural killer cells.Crit Rev Clin Lab Sci. 1986;22(4):343-59. doi: 10.3109/10408368509165790. Crit Rev Clin Lab Sci. 1986. PMID: 2419034 Review.
Cited by
-
Skin fibroblasts from individuals with Chediak-Higashi Syndrome (CHS) exhibit hyposensitive immunogenic response.Orphanet J Rare Dis. 2014 Dec 21;9:212. doi: 10.1186/s13023-014-0212-7. Orphanet J Rare Dis. 2014. PMID: 25528552 Free PMC article.
-
Differences in Granule Morphology yet Equally Impaired Exocytosis among Cytotoxic T Cells and NK Cells from Chediak-Higashi Syndrome Patients.Front Immunol. 2017 Apr 18;8:426. doi: 10.3389/fimmu.2017.00426. eCollection 2017. Front Immunol. 2017. PMID: 28458669 Free PMC article.
-
Defective postbinding lysis underlies the impaired natural killer activity in factor VIII-treated, human T lymphotropic virus type III seropositive hemophiliacs.J Clin Invest. 1986 Apr;77(4):1057-62. doi: 10.1172/JCI112404. J Clin Invest. 1986. PMID: 3007575 Free PMC article.
-
Human immunodeficiency syndromes affecting human natural killer cell cytolytic activity.Front Immunol. 2014 Jan 21;5:2. doi: 10.3389/fimmu.2014.00002. eCollection 2014. Front Immunol. 2014. PMID: 24478771 Free PMC article. Review.
-
Cytolytic mechanisms involved in non-MHC-restricted cytotoxicity in Chediak-Higashi syndrome.Clin Exp Immunol. 1999 Oct;118(1):108-14. doi: 10.1046/j.1365-2249.1999.01025.x. Clin Exp Immunol. 1999. PMID: 10540167 Free PMC article.